140 related articles for article (PubMed ID: 19189046)
21. Negative autoregulation of RANKL and c-Src signaling in osteoclasts.
Yogo K; Ishida-Kitagawa N; Takeya T
J Bone Miner Metab; 2007; 25(4):205-10. PubMed ID: 17593489
[No Abstract] [Full Text] [Related]
22. Phosphorylation of the phosphatase PTPROt at Tyr
Roth L; Wakim J; Wasserman E; Shalev M; Arman E; Stein M; Brumfeld V; Sagum CA; Bedford MT; Tuckermann J; Elson A
Sci Signal; 2019 Jan; 12(563):. PubMed ID: 30622194
[TBL] [Abstract][Full Text] [Related]
23. Targeting Src homology 2 domain-containing tyrosine phosphatase (SHP-1) into lipid rafts inhibits CD3-induced T cell activation.
Su MW; Yu CL; Burakoff SJ; Jin YJ
J Immunol; 2001 Mar; 166(6):3975-82. PubMed ID: 11238643
[TBL] [Abstract][Full Text] [Related]
24. c-Src-mediated phosphorylation of thyroid hormone receptor-interacting protein 6 (TRIP6) promotes osteoclast sealing zone formation.
McMichael BK; Meyer SM; Lee BS
J Biol Chem; 2010 Aug; 285(34):26641-51. PubMed ID: 20547766
[TBL] [Abstract][Full Text] [Related]
25. TULA-2, a novel histidine phosphatase, regulates bone remodeling by modulating osteoclast function.
Back SH; Adapala NS; Barbe MF; Carpino NC; Tsygankov AY; Sanjay A
Cell Mol Life Sci; 2013 Apr; 70(7):1269-84. PubMed ID: 23149425
[TBL] [Abstract][Full Text] [Related]
26. Protein-tyrosine phosphatases in development.
den Hertog J
Mech Dev; 1999 Jul; 85(1-2):3-14. PubMed ID: 10415342
[TBL] [Abstract][Full Text] [Related]
27. Interaction of Pyk2 and PTP-PEST with leupaxin in prostate cancer cells.
Sahu SN; Nunez S; Bai G; Gupta A
Am J Physiol Cell Physiol; 2007 Jun; 292(6):C2288-96. PubMed ID: 17329398
[TBL] [Abstract][Full Text] [Related]
28. The Src family kinase, Lyn, suppresses osteoclastogenesis in vitro and in vivo.
Kim HJ; Zhang K; Zhang L; Ross FP; Teitelbaum SL; Faccio R
Proc Natl Acad Sci U S A; 2009 Feb; 106(7):2325-30. PubMed ID: 19171907
[TBL] [Abstract][Full Text] [Related]
29. Dimerization in vivo and inhibition of the nonreceptor form of protein tyrosine phosphatase epsilon.
Toledano-Katchalski H; Tiran Z; Sines T; Shani G; Granot-Attas S; den Hertog J; Elson A
Mol Cell Biol; 2003 Aug; 23(15):5460-71. PubMed ID: 12861030
[TBL] [Abstract][Full Text] [Related]
30. Roles of protein-tyrosine phosphatases in growth factor signalling.
Matozaki T; Kasuga M
Cell Signal; 1996 Jan; 8(1):13-9. PubMed ID: 8777136
[TBL] [Abstract][Full Text] [Related]
31. LAR protein tyrosine phosphatase receptor associates with TrkB and modulates neurotrophic signaling pathways.
Yang T; Massa SM; Longo FM
J Neurobiol; 2006 Nov; 66(13):1420-36. PubMed ID: 17013927
[TBL] [Abstract][Full Text] [Related]
32. Src kinase regulation by phosphorylation and dephosphorylation.
Roskoski R
Biochem Biophys Res Commun; 2005 May; 331(1):1-14. PubMed ID: 15845350
[TBL] [Abstract][Full Text] [Related]
33. On the cross-regulation of protein tyrosine phosphatases and receptor tyrosine kinases in intracellular signaling.
Haugh JM; Schneider IC; Lewis JM
J Theor Biol; 2004 Sep; 230(1):119-32. PubMed ID: 15276005
[TBL] [Abstract][Full Text] [Related]
34. The role of protein tyrosine phosphatases in the regulation of allergic asthma: implication of TC-PTP and PTP-1B in the modulation of disease development.
Pouliot P; Bergeron S; Marette A; Olivier M
Immunology; 2009 Dec; 128(4):534-42. PubMed ID: 19930043
[TBL] [Abstract][Full Text] [Related]
35. PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase.
Duong LT; Lakkakorpi PT; Nakamura I; Machwate M; Nagy RM; Rodan GA
J Clin Invest; 1998 Sep; 102(5):881-92. PubMed ID: 9727056
[TBL] [Abstract][Full Text] [Related]
36. Tyrosine phosphatase epsilon is a positive regulator of osteoclast function in vitro and in vivo.
Chiusaroli R; Knobler H; Luxenburg C; Sanjay A; Granot-Attas S; Tiran Z; Miyazaki T; Harmelin A; Baron R; Elson A
Mol Biol Cell; 2004 Jan; 15(1):234-44. PubMed ID: 14528021
[TBL] [Abstract][Full Text] [Related]
37. Src homology 2 domain-containing protein-tyrosine phosphatases, SHP-1 and SHP-2, are required for platelet endothelial cell adhesion molecule-1/CD31-mediated inhibitory signaling.
Henshall TL; Jones KL; Wilkinson R; Jackson DE
J Immunol; 2001 Mar; 166(5):3098-106. PubMed ID: 11207261
[TBL] [Abstract][Full Text] [Related]
38. Tyrosine phosphatases such as SHP-2 act in a balance with Src-family kinases in stabilization of postsynaptic clusters of acetylcholine receptors.
Camilleri AA; Willmann R; Sadasivam G; Lin S; Rüegg MA; Gesemann M; Fuhrer C
BMC Neurosci; 2007 Jul; 8():46. PubMed ID: 17605785
[TBL] [Abstract][Full Text] [Related]
39. Src kinase activity is essential for osteoclast function.
Miyazaki T; Sanjay A; Neff L; Tanaka S; Horne WC; Baron R
J Biol Chem; 2004 Apr; 279(17):17660-6. PubMed ID: 14739300
[TBL] [Abstract][Full Text] [Related]
40. Low Molecular Weight Protein Tyrosine Phosphatase Slow Isoform Knockdown in MDA-MB-435 Cells Decreases RAW 264.7 Osteoclastic Differentiation.
Alho I; Costa L; Bicho M; Coelho C
Anticancer Res; 2016 May; 36(5):2227-32. PubMed ID: 27127127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
